Finland· FI-REL-REL8084
Ledercort Acetonid
A triamcinolone product, registered in Finland by Wyeth Lederle Nordiska Ab. The same ATC class is registered in 7 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Triamcinolone is registered in 7 of 19 countries.
Countries holding a registration under ATC D07AB09 (triamcinolone), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 4 of them publish a price we can compare per daily dose
Triamcinolone · ATC D07AB09
7 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Netherlands
- United Statesprice
The record
At a glance
Fimea (Finland)- Manufacturer
- Wyeth Lederle Nordiska Ab
- Country
- Finland (FI)
- ATC code
- D07AB09
- ATC class
- Triamcinolone
- Defined daily dose
- 2 mg, T
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
55 interactions on record for triamcinolone.
Graded by severity as the source publishes them — 55 minor. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Triamcinolone · interactions on record
55 records
Same class
Other records under D07AB09
Triamcinolone, as other registers publish it.
- CanadaARISTOCORT CBAUSCH HEALTH, CANADA INC.
- CanadaARISTOCORT RBAUSCH HEALTH, CANADA INC.
- CanadaARISTOCORT RBAUSCH HEALTH, CANADA INC.
- BelgiumDelphi 0.1 %BePharBel Manufacturing
- FinlandKenacort-TE.R. Squibb & Sons Limited
- GermanyKortikoidRatiopharm Gmbh
- GermanyKortikoid-RatiopharmRatiopharm Gmbh
- United StatesKOURZEQMidAmerica Pharmaceuticals
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ea1e117e-7a80-4298-b5d3-b27cb1293f3e GET /v1/drugs/ea1e117e-7a80-4298-b5d3-b27cb1293f3e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "emulsiovoide",
"route": null,
"ddd_unit": null,
"strength": "0.1 %",
"atc_label": "triamsinoloni",
"ma_number": "2848",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL8084",
"authorised_at": "1966-01-19"
}See everything about triamcinolone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.